Acute inhalation toxicity of silver nanoparticles

Area of Science:

• Toxicology
• Nanotechnology
• Environmental Health

Background:

• Silver nanoparticles (AgNPs) are increasingly used in consumer products.
• Understanding the potential health risks of AgNPs, particularly via inhalation, is crucial.
• Limited data exists on the acute inhalation toxicity of AgNPs in mammalian models.

Purpose of the Study:

• To determine the acute inhalation toxicity of silver nanoparticles in Sprague-Dawley rats.
• To establish the lethal concentration 50 (LC50) for inhaled silver nanoparticles.
• To assess the impact of AgNP inhalation on animal health and pulmonary function.

Main Methods:

• Adult Sprague-Dawley rats were exposed to varying concentrations of AgNPs (average diameter 18-20 nm) for 4 hours in a whole-body inhalation chamber.
• The study followed OECD test guideline 403 under good laboratory practice (GLP) conditions.
• Parameters monitored included mortality, clinical signs, body weight, food consumption, pulmonary function, and organ weights post-necropsy.

Main Results:

• No significant changes in body weight, food consumption, or clinical observations were noted during the 2-week study period.
• Pulmonary function tests revealed no significant differences between the fresh-air control group and rats exposed to silver nanoparticles.
• No mortality was observed at the highest tested concentration of 3.08 × 10(6) particles/cm(3) (750 µg/m(3)).

Conclusions:

• The acute inhalation toxicity of silver nanoparticles in Sprague-Dawley rats appears to be low.
• The LC50 for silver nanoparticles is estimated to be greater than 3.1 × 10(6) particles/cm(3) (750 µg/m(3)).
• Further studies may be warranted to investigate sub-chronic or chronic inhalation effects of silver nanoparticles.